Skip to main content Skip to secondary navigation

Publications

Main content start
Jean Tang photo

Jean Y. Tang MD PhD

Professor of Dermatology

Publications

  • Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases So, J. Y., Nazaroff, J., Iwummadu, C. V., Harris, N., Gorell, E. S., Fulchand, S., Bailey, I., McCarthy, D., Siprashvili, Z., Marinkovich, M. P., Tang, J. Y., Chiou, A. S. 2022; 17 (1): 377
    DOI 10.1186/s13023-022-02546-9
    PubMedID 36253825
  • Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series. Journal of The American Academy of Dermatology Betancourt, N. J., Sum, K., Gorell, E. S., Tang, J. Y., Chiou, A. S. 2022
    DOI 10.1016/j.jaad.2022.08.030
    PubMedID 36007691
  • A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex. Orphanet Journal of Rare Diseases So, J. Y., Fulchand, S., Wong, C. Y., Li, S., Nazaroff, J., Gorell, E. S., de Souza, M. P., Murrell, D. F., Teng, J. M., Chiou, A. S., Tang, J. Y. 2022; 17 (1): 270
    DOI 10.1186/s13023-022-02433-3
    PubMedID 35841105
  • Gorlin syndrome: assessing genotype-phenotype correlations and analysis of early clinical characteristics as risk factors for disease severity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology Betancourt, N. J., Qian, M. F., Pickford, J. R., Bailey-Healy, I., Tang, J. Y., Teng, J. M. 2022: JCO2102385
    DOI 10.1200/JCO.21.02385
    PubMedID 35333541
  • A retrospective analysis of diagnostic testing in a large north american cohort of patients with epidermolysis bullosa. Journal of the American Academy of Dermatology Phillips, G. S., Huang, A., Augsburger, B. D., Kaplan, L., Peoples, K., Bruckner, A. L., Khuu, P., Tang, J. Y., Lara-Corrales, I., Pope, E., Wiss, K., Levin, L. E., Morel, K. D., Hook, K. P., Paller, A. S., Eichenfield, L. F., McCuaig, C. C., Powell, J., Castelo-Soccio, L., Levy, M. L., Price, H. N., Schachner, L. A., Browning, J. C., Jahnke, M., Shwayder, T., Bayliss, S., Lucky, A. W., Glick, S. A. 2021
    DOI 10.1016/j.jaad.2021.09.065
    PubMedID 34634382
  • Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: a global cross-sectional survey. Pediatric Dermatology Fulchand, S., Harris, N., Li, S., Barriga, M., Gorell, E., De Souza, M., Murrell, D., Marinkovich, P., Krishna Yenamandra, V., Tang, J. Y. 2021
    DOI 10.1111/pde.14802
    PubMedID 34515355
  • Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study. Orphanet Journal of Rare Diseases Schrader, N. H., Gorell, E. S., Stewart, R. E., Duipmans, J. C., Harris, N., Perez, V. A., Tang, J. Y., Wolff, A. P., Bolling, M. C. 2021; 16 (1): 377
    DOI 10.1186/s13023-021-02010-0
    PubMedID 34488820
  • Validity and accuracy of a mobile phone application for the assessment of wounds in recessive dystrophic epidermolysis bullosa. Journal of the American Academy of Dermatology Nazaroff, J., Solis, D., Barriga, M., Dutt-Singkh, Y., Li, S., Marinkovich, P. M., Tang, J. Y. 2021; 85 (2): 468-469
    DOI 10.1016/j.jaad.2017.11.023
    Web of Science ID 000687299800055
  • Measurement of skin adhesion in recessive dystrophic epidermolysis bullosa patients. Journal of the American Academy of Dermatology Nazaroff, J., Manoukian, M., Barriga, M., Lane, A., Marinkovich, M., Tang, J. Y. 2021; 85 (2): 491-492
    DOI 10.1016/j.jaad.2018.07.034
    Web of Science ID 000687299800034
  • A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases Tang, J. Y., Marinkovich, M. P., Lucas, E., Gorell, E., Chiou, A., Lu, Y., Gillon, J., Patel, D., Rudin, D. 2021; 16 (1): 175
    DOI 10.1186/s13023-021-01811-7
  • Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology Solis, D. C., Gorell, E. S., Teng, C., Barriga, M., Nazaroff, J., Li, S., Subica, A., Lu, Y., Marinkovich, M. P., Tang, J. Y. 2021
    DOI 10.1111/pde.14576
    PubMedID 33749033
  • A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases Tang, J. Y., Marinkovich, M. P., Lucas, E., Gorell, E., Chiou, A., Lu, Y., Gillon, J., Patel, D., Rudin, D. 2021; 16 (1): 175
  • DOI 10.1186/s13023-021-01811-7
  • Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology Solis, D. C., Gorell, E. S., Teng, C., Barriga, M., Nazaroff, J., Li, S., Subica, A., Lu, Y., Marinkovich, M. P., Tang, J. Y. 2021
    DOI 10.1111/pde.14576
    PubMedID 33749033
  • Direct-to-consumer genetic risk scoring for melanoma improves adherence to sun-protective behaviors among increased-risk groups: Results from a prospective U.S. cohort study. Journal of the American Academy of Dermatology Hu, X. n., Kilgour, J. M., Fogel, A. L., Jia, J. L., Jaju, P. D., Tang, J. Y., Sarin, K. Y. 2021
    DOI 10.1016/j.jaad.2021.01.042
    PubMedID 33476728
  • Financial burden of epidermolysis bullosa on patients in the United States. Pediatric Dermatology Gorell, E. S., Wolstencroft, P. W., de Souza, M. P., Murrell, D. F., Linos, E., Tang, J. Y. 2020
    DOI 10.1111/pde.14340
  • Multidisciplinary care of epidermolysis bullosa during the covid-19 pandemic - consensus: recommendations by an international panel of experts. Journal of the American Academy of Dermatology Murrell, D. F., Lucky, A. W., Salas-Alanis, J. C., Woodley, D. T., Palisson, F., Natsuga, K., Nikolic, M., Ramirez-Quizon, M., Paller, A. S., Lara-Corrales, I., Barzegar, M. A., Sprecher, E., Has, C., Laimer, M., Bruckner, A. L., Bilgic, A., Nanda, A., Purvis, D., Hovnanian, A., Murat-Susic, S., Bauer, J., Kern, J. S., Bodemer, C., Martin, L. K., Mellerio, J., Kowaleski, C., Robertson, S. J., Bruckner-Tuderman, L., Pope, E., Marinkovich, M. P., Tang, J. Y., Su, J., Uitto, J., Eichenfield, L. F., Teng, J., Aan Koh, M. J., Lee, S. E., Khuu, P., Rishel, H. I., Sommerlund, M., Wiss, K., Hsu, C., Chiu, T. W., Martinez, A. E. 2020
    DOI 10.1016/j.jaad.2020.06.1023
    PubMedID 32682031
  • The association between cigarette smoking, cancer screening, and cancer stage: A prospective study of the women's health initiative observational cohort. BMJ Open Eng, V. A., David, S. P., Li, S. n., Ally, M. S., Stefanick, M. n., Tang, J. Y. 2020; 10 (8): e037945
    DOI 10.1136/bmjopen-2020-037945
    PubMedID 32796021
  • Induced remission of metastatic squamous cell carcinoma with an immune checkpoint inhibitor in a patient with recessive dystrophic epidermolysis bullosa. Case Reports in Oncology Khaddour, K. n., Gorell, E. S., Dehdashti, F. n., Tang, J. Y., Ansstas, G. n. 2020; 13 (2): 911–15
    DOI 10.1159/000508933
    PubMedID 32884539
  • Patient reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. Journal of the American Academy of Dermatology Eng, V. A., Solis, D. C., Gorell, E. S., Choi, S. n., Nazaroff, J. n., Li, S. n., de Souza, M. P., Murrell, D. F., Marinkovich, M. P., Tang, J. Y. 2020
    DOI 10.1016/j.jaad.2020.03.028
    PubMedID 32199895
  • From clinical phenotype to genotypic modelling: Incidence and prevalence of recessive dystrophic epidermolysis bullosa (rdeb). Clinical, Cosmetic and Investigational Dermatology Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., Schu, M., Fang, F., Erickson, S. W., Ritchey, M. E., Colao, M., Spratt, K., Shaygan, A., Ahn, M. J., Sarin, K. Y. 2019; 12: 933-942
    DOI 10.2147/CCID.S232547
    PubMedID 31920360
    Web of Science ID 000503975800001
  • Gene therapy for epidermolysis bullosa. Journal of Investigative Dermatology Marinkovich, M., Tang, J. Y. 2019; 139 (6): 1221–26
    DOI 10.1016/j.jid.2018.11.036
    Web of Science ID 000468701800015
  • Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North America. Jama Dermatology Feinstein, J. A., Jambal, P., Peoples, K., Lucky, A. W., Phuong Khuu, Tang, J. Y., Lara-Corrales, I., Pope, E., Wiss, K., Hook, K. P., Levin, L. E., Morel, K. D., Paller, A. S., McCuaig, C. C., Powell, J., Eichenfield, L. F., Price, H., Levy, M. L., Schachner, L. A., Browning, J. C., Bayliss, S., Jahnke, M., Shwayder, T., Glick, S. A., Bruckner, A. L. 2019; 155 (2): 196–203
    DOI 10.1001/jamadermatol.2018.4673
    Web of Science ID 000458611700009
    PubMedID 30586139
  • Genetic mutations underlying phenotypic plasticity in basosquamous carcinoma. Journal of Investigative Dermatology Chiang, A., Tan, C. Z., Kuonen, F., Hodgkinson, L. M., Chiang, F., Cho, R. J., South, A. P., Tang, J. Y., Chang, A. L., Rieger, K. E., Oro, A. E., Sarin, K. Y. 2019
    DOI 10.1016/j.jid.2019.03.1163
  • Topical itraconazole for the treatment of basal cell carcinoma in patients with basal cell nevus syndrome or high-frequency basal cell carcinomas: A phase 2, open-label, placebo-controlled trial. Jama Dermatology Sohn, G. K., Kwon, G. P., Bailey-Healy, I. n., Mirza, A. n., Sarin, K. n., Oro, A. n., Tang, J. Y. 2019
    DOI 10.1001/jamadermatol.2019.1541
    PubMedID 31339515
  • Screening clinical cell products for replication competent retrovirus: The national gene vector biorepository experience. Molecular Therapy-Methods & Clinical Development Cornetta, K., Duffy, L., Feldman, S. A., Mackall, C. L., Davila, M. L., Curran, K. J., Junghans, R. P., Tang, J., Kochenderfer, J. N., O'Cearbhaill, R., Archer, G., Kiem, H., Shah, N. N., Delbrook, C., Kaplan, R., Brentjens, R. J., Riviere, I., Sadelain, M., Rosenberg, S. A. 2018; 10: 371–78
    PubMedID 30211249
  • Association of 25-hydroxyvitamin d levels and cutaneous melanoma: A nested case-control study of the women's health initiative observation study. Journal of the American Academy of Dermatology Kwon, G. P., Gamba, C. S., Stefanick, M. L., Swetter, S. M., Li, S., Shi, R. Z., Clarke, C. A., Feldman, D., Millen, A. E., Messina, C., Shikany, J. M., Manson, J. E., Chlebowski, R. T., Tang, J. Y. 2018; 79 (1): 145–47
    PubMedID 29908819
  • Melanoma risk prediction using a multilocus genetic risk score in the women's health initiative cohort. Journal of the American Academy of Dermatology Cho, H. G., Ransohoff, K. J., Yang, L., Hedlin, H., Assimes, T., Han, J., Stefanick, M., Tang, J. Y., Sarin, K. Y. 2018; 79 (1): 36-+
    DOI 10.1016/j.jaad.2018.02.052
    Web of Science ID 000438597000012
  • Risk of melanoma with phosphodiesterase type 5 inhibitor use among patients with erectile dysfunction, pulmonary hypertension, and lower urinary tract symptoms. The Journal of Sexual Medicine Shkolyar, E., Li, S., Tang, J., Eisenberg, M. L. 2018
    PubMedID 29884444
  • Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece. The British Journal of Dermatology Wehner, M. R., Dalma, N., Landefeld, C., Pare-Anastasiadou, A., Koutelidas, I., Chren, M. M., Aji, N., Teng, C. E., Koenig, B. A., Tang, J., Covinsky, K., Linos, E. 2018
    DOI 10.1111/bjd.16730
    PubMedID 29741766
  • Serlopitant for the treatment of chronic pruritus: results of a randomized, multicenter, placebo-controlled phase 2 clinical trial. Journal of the American Academy of Dermatology Yosipovitch, G., Stander, S., Kerby, M. B., Larrick, J. W., Perlman, A. J., Schnipper, E. F., Zhang, X., Tang, J. Y., Luger, T., Steinhoff, M. 2018; 78 (5): 882-+
    PubMedID 29462657
  • Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nature Medicine Whitson, R. J., Lee, A. n., Urman, N. M., Mirza, A. n., Yao, C. Y., Brown, A. S., Li, J. R., Shankar, G. n., Fry, M. A., Atwood, S. X., Lee, E. Y., Hollmig, S. T., Aasi, S. Z., Sarin, K. Y., Scott, M. P., Epstein, E. H., Tang, J. Y., Oro, A. E. 2018; 24 (3): 271–81
    PubMedID 29400712
    PubMedCentralID PMC5839965
  • Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging. Proceedings of the National Academy of Sciences of the United States of America Margulis, K. n., Chiou, A. S., Aasi, S. Z., Tibshirani, R. J., Tang, J. Y., Zare, R. N. 2018
    PubMedID 29866838
  • Neuronal delivery of hedgehog directs spatial patterning of taste organ regeneration. Proceedings of the National Academy of Sciences of the United States of America Lu, W. J., Mann, R. K., Nguyen, A. n., Bi, T. n., Silverstein, M. n., Tang, J. Y., Chen, X. n., Beachy, P. A. 2018; 115 (2): E200–E209
    PubMedID 29279401
    PubMedCentralID PMC5777079
  • Azathioprine and risk of multiple keratinocyte cancers. Journal of the American Academy of Dermatology Cho, H. G., Kuo, K. Y., Xiao, K. n., Batra, P. n., Li, S. n., Tang, J. Y., Sarin, K. Y. 2018; 78 (1): 27–28.e1
    PubMedID 28989107
  • Validity and accuracy of a mobile phone application for the assessment of wounds in recessive dystrophic epidermolysis bullosa. Journal of the American Academy of Dermatology Nazaroff, J., Solis, D., Barriga, M., Dutt-Singkh, Y., Shufeng, L., Marinkovich, M. P., Tang, J. Y. 2017
    PubMedID 29146128
  • Statin use and non-melanoma skin cancer risk: A meta-analysis of randomized controlled trials and observational studies. Oncotarget Yang, K., Marley, A., Tang, H., Song, Y., Tang, J. Y., Han, J. 2017; 8 (43): 75411–17
    PubMedID 29088876
  • Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes. Cancer Epidemiology Biomarkers & Prevention Ko, J. S., Matharoo-Ball, B., Billings, S., Thomson, B. J., Tang, J. Y., Sarin, K. Y., Cai, E., Kim, J., Rock, C., Kimbrell, H. Z., Flake, D. D., Warf, M., Nelson, J., Davis, T., Miller, C., Rushton, K., Hartman, A., Wenstrup, R. J., Clarke, L. E. 2017; 26 (7): 1107–13
    PubMedID 28377414
  • Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution. Journal of the American Academy of Dermatology Kuo, K. Y., Batra, P., Cho, H. G., Li, S., Chahal, H. S., Rieger, K. E., Tang, J. Y., Sarin, K. Y. 2017
    DOI 10.1016/j.jaad.2017.02.047
    PubMedID 28392289
  • Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. Oncotarget Ransohoff, K. J., Wu, W., Cho, H. G., Chahal, H. C., Lin, Y., Dai, H., Amos, C. I., Lee, J. E., Tang, J. Y., Hinds, D. A., Han, J., Wei, Q., Sarin, K. Y. 2017
    DOI 10.18632/oncotarget.15230
    PubMedID 28212542
    PubMedCentralID PMC5392271
  • Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma. International Journal of Cancer Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Dai, H., Tang, J. Y., Sarin, K. Y., Han, J. 2017
    DOI 10.1002/ijc.30634
    PubMedID 28177523
  • Risk factors for basal cell carcinoma among patients with basal cell nevus syndrome development of a basal cell nevus syndrome patient registry. Jama Dermatology Solis, D. C., Kwon, G. P., Ransohoff, K. J., Li, S., Chahal, H. S., Ally, M. S., Peters, M. A., Schmitt-Burr, K., Lindgren, J., Bailey-Healy, I., Teng, J. M., Epstein, E. H., Tang, J. Y. 2017; 153 (2): 189-192
    DOI 10.1001/jamadermatol.2016.4347
    Web of Science ID 000395670800017
  • Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk. Journal of the American Academy of Dermatology Fogel, A. L., Jaju, P. D., Li, S., Halpern-Felsher, B., Tang, J. Y., Sarin, K. Y. 2017
    DOI 10.1016/j.jaad.2016.11.050
    PubMedID 28087134
  • Height, height-related SNPs, and risk of non-melanoma skin cancer. British Journal of Cancer Li, X., Liang, L., Feng, Y., De Vivo, I., Giovannucci, E., Tang, J. Y., Han, J. 2017; 116 (1): 134–40
    PubMedID 27846199
    PubMedCentralID PMC5220142
  • Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment. JCI Insight Mirza, A. N., Fry, M. A., Urman, N. M., Atwood, S. X., Roffey, J. n., Ott, G. R., Chen, B. n., Lee, A. n., Brown, A. S., Aasi, S. Z., Hollmig, T. n., Ator, M. A., Dorsey, B. D., Ruggeri, B. R., Zificsak, C. A., Sirota, M. n., Tang, J. Y., Butte, A. n., Epstein, E. n., Sarin, K. Y., Oro, A. E. 2017; 2 (21)
    PubMedID 29093271
  • Genomic stability in syndromic basal cell carcinoma. The Journal of Investigative Dermatology Chiang, A. n., Jaju, P. D., Batra, P. n., Rezaee, M. n., Epstein, E. H., Tang, J. Y., Sarin, K. Y. 2017
    PubMedID 29111235
  • Tumor-derived suppressor of fused mutations reveal hedgehog pathway interactions. Plos One Urman, N. M., Mirza, A., Atwood, S. X., Whitson, R. J., Sarin, K. Y., Tang, J. Y., Oro, A. E. 2016; 11 (12)
    DOI 10.1371/journal.pone.0168031
    Web of Science ID 000391222000030
    PubMedID 28030567
    PubMedCentralID PMC5193403
  • Protective effects of statins in cancer: Should they be prescribed for high-risk patients? Current Atherosclerosis Reports Wang, A., Wakelee, H. A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. E., Stefanick, M. L. 2016; 18 (12): 72-?
    PubMedID 27796821
  • A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma. Carcinogenesis Li, X., Cornelis, M. C., Liang, L., Song, F., De Vivo, I., Giovannucci, E., Tang, J. Y., Han, J. 2016; 37 (12): 1138–43
    PubMedID 27797824
    PubMedCentralID PMC5137266

See all 140 publications